Sales rise 8.05% to Rs 1630.57 crore
Net profit of Alembic Pharmaceuticals rose 48.01% to Rs 180.45 crore in the quarter ended December 2023 as against Rs 121.92 crore during the previous quarter ended December 2022. Sales rose 8.05% to Rs 1630.57 crore in the quarter ended December 2023 as against Rs 1509.02 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales1630.571509.02 8 OPM %16.3315.58 -PBDT254.04221.00 15 PBT184.59154.49 19 NP180.45121.92 48Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
